GREER® Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced two product theater presentations to take place during the American College of Allergy, Asthma and Immunology (ACAAI) 2014 Annual Scientific Meeting being held November 6-10 in Atlanta, Georgia. ORALAIR® (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for any of the five grass species contained in this product. ORALAIR is approved for use in persons 10 through 65 years of age.
Help employers find you! Check out all the jobs and post your resume.
